Pascal Soriot, AstraZeneca CEO (Zach Gibson/Bloomberg via Getty Images)
April 28, 2021 07:34 AM EDT
Coronavirus

Covid-19 roundup: Eu­ro­pean Com­mis­sion's le­gal bat­tle against As­traZeneca be­gins; Kaza­khstan gives green light to do­mes­tic vac­cine

Nicole DeFeudis

Editor

The Eu­ro­pean Com­mis­sion’s le­gal case against As­traZeneca for fail­ing to de­liv­er the amount of vac­cine dos­es laid out in a con­tract be­gan in a Brus­sels …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times